{"version":"1.0","type":"link","title":"Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy.","author_name":"Shai A 외","author_url":"https://prs-insight.online/author/Shai%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/87139","thumbnail_width":1200,"thumbnail_height":630}